PRRSV-Vaccinated, Seronegative Sows and Maternally Derived Antibodies (II): Impact on PRRSV-1 Vaccine Effectiveness and Challenge Outcomes in Piglets

Jorian Fiers,Dominiek Maes,Ann-Brigitte Cay,Frank Vandenbussche,Laurent Mostin,Anna Parys,Marylène Tignon

DOI: https://doi.org/10.3390/vaccines12030257

2024-03-02

Vaccines

Abstract:Vaccination against the Porcine Reproductive and Respiratory Syndrome virus (PRRSV) is widely practiced in both sows and piglets. However, it has been shown that multivaccinated sows sometimes lack a detectable antibody response, testing seronegative in ELISA (non-responders). Moreover, PRRSV-vaccinated piglets can remain seronegative as well, which is mainly attributed to the interference of maternally derived antibodies (MDAs). The current study investigated the impact of the sow's immune status on the PRRSV vaccine effectiveness in the progeny. The experimental trial included forty-eight piglets (n = 48) originating from a commercial Belgian breeding herd, with twenty-four piglets born from PRRSV vaccinated responder sows (E+ piglets) and twenty-four piglets born from PRRSV vaccinated non-responder sows (E− piglets). Eight piglets in each group were either non-vaccinated (NoVac piglets; n = 8), intramuscularly vaccinated (IM piglets; n = 8), or intradermally vaccinated (ID piglets; n = 8), with the same PRRSV-1 vaccine as used in the sow population. Vaccination was performed at weaning at three weeks of age, and all study piglets were challenged with a high dose of the PRRSV-1 07V063 strain at 6 weeks of age. A clear interference of MDAs was observed in the E+ piglets: 66.7% of the vaccinated E+ piglets lacked an antibody response at 3 weeks post-vaccination (non-responders). Consequently, post-challenge, only the responding E+ piglets had a significantly reduced serum viremia compared to the E+ NoVac piglets. The observed viremia in the non-responding E+ piglets was similar to the viremia of the E+ NoVac piglets. In the vaccinated E− piglets, a lack of antibody response at 3 weeks post-vaccination was observed in 18.8% of the piglets. Interestingly, despite the lack of a vaccine antibody response, the non-responding E− piglets had a significantly reduced serum viremia compared to the NoVac E− piglets. In contrast, the viremia of the responding E− piglets was only numerically reduced compared to the NoVac E− piglets. Finally, some clear differences were observed in both the kinetics of infection and the immune responses post-challenge between the E+ and E− piglets. The results of this study confirm the consequences of the MDA interference on the induced partial protection of PRRSV vaccination in experimentally challenged piglets. More research is warranted to understand the immunological mechanisms behind MDA interference in PRRSV vaccination and to explain the observed differences between E+ and E− piglets.

immunology,medicine, research & experimental

What problem does this paper attempt to address?

The paper primarily explores the effectiveness of the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccine in piglets, with a particular focus on the impact of maternal antibodies (MDAs) on vaccine efficacy.

Specifically, the study aims to evaluate the immune response and subsequent challenge test results in piglets born to sows that were serologically positive (i.e., produced detectable antibodies, referred to as responders) and serologically negative (did not produce detectable antibodies, referred to as non-responders) after being vaccinated with the PRRSV vaccine.

The study hypotheses include:
1. Piglets born to non-responder sows may exhibit better vaccine efficacy due to the lack of MDAs, as they would not be interfered with by MDAs.
2. On the other hand, these piglets might also show a weaker response to the vaccine due to the impaired immune response of the sows themselves.

To investigate these issues, the researchers designed an experimental protocol that included:
- Selecting piglets from commercial pig farms where sows were routinely vaccinated with the PRRSV-1 vaccine.
- Dividing the piglets into two groups based on the serological response status of the sows: one group from responder sows (E+ piglets) and the other from non-responder sows (E- piglets).
- Further subdividing each group of piglets based on different vaccination methods: no vaccination (NoVac), intramuscular vaccination (IM), or intradermal vaccination (ID).
- All piglets were vaccinated with the same PRRSV-1 vaccine at weaning and challenged with a high dose of the PRRSV-1 strain at 6 weeks of age.

The main results indicated:
- A significant interference effect of MDAs was observed in E+ piglets, with most vaccinated piglets failing to produce an antibody response 3 weeks post-vaccination.
- In contrast, only a few individuals in the E- piglets failed to produce an antibody response 3 weeks post-vaccination.
- Although non-responders among the E- piglets did not produce a vaccine antibody response, their serum viral load was significantly reduced after the challenge test, showing improvement compared to NoVac E- piglets.
- While responders among the E+ piglets did produce an antibody response, their serum viral load was only numerically reduced.

In summary, the study confirmed the impact of MDAs on the partial protective effect induced by the PRRSV vaccine and revealed some differences in immune responses between E+ and E- piglets. The authors suggest further research is needed to understand the mechanisms of MDA interference and its specific impact on vaccine efficacy.